Harvard Medical School Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Harvard Medical School Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Trends Genet. 2022 Aug;38(8):821-830. doi: 10.1016/j.tig.2022.03.013. Epub 2022 Apr 19.
The family of adenosine deaminases acting on RNA (ADARs) regulates global gene expression output by catalyzing adenosine-to-inosine (A-to-I) editing of double-stranded RNA (dsRNA) and through interacting with RNA and other proteins. ADARs play important roles in development and disease, including an increasing connection to cancer progression. ADAR1 has demonstrated a largely pro-oncogenic role in a growing list of cancer types, and its function in cancer has been attributed to diverse mechanisms. Here, we review existing literature on ADAR1 biology and function, its roles in human disease including cancer, and summarize known cancer-associated phenotypes and mechanisms. Lastly, we discuss implications and outstanding questions in the field, including strategies for targeting ADAR1 in cancer.
腺苷脱氨酶作用于 RNA 的家族 (ADARs) 通过催化双链 RNA (dsRNA) 中的腺苷到肌苷 (A-to-I) 编辑,并通过与 RNA 和其他蛋白质相互作用,调节全球基因表达输出。ADARs 在发育和疾病中发挥着重要作用,包括与癌症进展的联系越来越紧密。ADAR1 在越来越多的癌症类型中表现出主要的致癌作用,其在癌症中的功能归因于多种机制。在这里,我们回顾了 ADAR1 生物学和功能的现有文献,它在包括癌症在内的人类疾病中的作用,并总结了已知的与癌症相关的表型和机制。最后,我们讨论了该领域的意义和悬而未决的问题,包括在癌症中靶向 ADAR1 的策略。